Anti-UBE2J2 monoclonal antibody

Pre-made anti-UBE2J2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to UBE2J2/UBE2J2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2221-Ab-1/ GM-Tg-hg-IP2221-Ab-2Anti-Human UBE2J2 monoclonal antibodyHuman
GM-Tg-rg-IP2221-Ab-1/ GM-Tg-rg-IP2221-Ab-2Anti-Rat UBE2J2 monoclonal antibodyRat
GM-Tg-mg-IP2221-Ab-1/ GM-Tg-mg-IP2221-Ab-2Anti-Mouse UBE2J2 monoclonal antibodyMouse
GM-Tg-cynog-IP2221-Ab-1/ GM-Tg-cynog-IP2221-Ab-2Anti-Cynomolgus/ Rhesus macaque UBE2J2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2221-Ab-1/ GM-Tg-felg-IP2221-Ab-2Anti-Feline UBE2J2 monoclonal antibodyFeline
GM-Tg-cang-IP2221-Ab-1/ GM-Tg-cang-IP2221-Ab-2Anti-Canine UBE2J2 monoclonal antibodyCanine
GM-Tg-bovg-IP2221-Ab-1/ GM-Tg-bovg-IP2221-Ab-2Anti-Bovine UBE2J2 monoclonal antibodyBovine
GM-Tg-equg-IP2221-Ab-1/ GM-Tg-equg-IP2221-Ab-2Anti-Equine UBE2J2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2221-Ab-1/ GM-Tg-hg-IP2221-Ab-2; GM-Tg-rg-IP2221-Ab-1/ GM-Tg-rg-IP2221-Ab-2;
GM-Tg-mg-IP2221-Ab-1/ GM-Tg-mg-IP2221-Ab-2; GM-Tg-cynog-IP2221-Ab-1/ GM-Tg-cynog-IP2221-Ab-2;
GM-Tg-felg-IP2221-Ab-1/ GM-Tg-felg-IP2221-Ab-2; GM-Tg-cang-IP2221-Ab-1/ GM-Tg-cang-IP2221-Ab-2;
GM-Tg-bovg-IP2221-Ab-1/ GM-Tg-bovg-IP2221-Ab-2; GM-Tg-equg-IP2221-Ab-1/ GM-Tg-equg-IP2221-Ab-2
Products NameAnti-UBE2J2 monoclonal antibody
Formatmab
Target NameUBE2J2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-UBE2J2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2221-Ag-1Recombinant multi-species UB2J2/ UBE2J2/ NCUBE-2 protein


    Target information

    Target IDGM-IP2221
    Target NameUBE2J2
    Gene ID118424,140499,298689,700798,606935,101101628,506103,100061534
    Gene Symbol and Synonyms1200007B18Rik,2400008G19Rik,5730472G04Rik,NCUBE-2,NCUBE2,PRO2121,UBC6,Ubc6p,UBE2J2
    Uniprot AccessionQ8N2K1,Q2TA03
    Uniprot Entry NameUB2J2_HUMAN,UB2J2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160087
    Target ClassificationN/A

    The target: UBE2J2, gene name: UBE2J2, also named as NCUBE-2, NCUBE2, PRO2121. The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is located in the membrane of the endoplasmic reticulum. Multiple alternatively spliced transcript variants have been found for this gene, but the full-length nature of some variants has not been defined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.